# MEDGm reviews (2026): GLP-1 telehealth sellers | This GLP All three figures are memberships. The medication cost is written as a word, not a number. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/medgm Updated: 2026-10-28 Partner By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Membership plus an unstated cost # MEDGm review All three figures are memberships. The medication cost is written as a word, not a number. ## The verdict MEDGm publishes $171, $99 and $99 across three lines. Each is labeled 'Membership + Cost'. The cost half is not published anywhere. Coverage is stated across 51 jurisdictions. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral States 51 Prescription Required Compounded No Availability 51 jurisdictions MEDGm sells semaglutide and tirzepatide, injected and oral. Three lines carry a figure. Every one of them prices the membership and leaves the medication open. 1. ## Who writes the prescription, and what do they see? The membership is the route to a prescriber. A prescription follows. MEDGm notes that Ozempic is FDA-approved for type 2 diabetes and prescribed off-label for weight here. Few sellers state the off-label position that plainly. The pricing formula is printed on the page: membership plus cost. Naming the structure is a disclosure. Leaving the second term blank is the opposite. A buyer knows exactly what they will owe and exactly what they will not. 2. ## What happens when the dose goes up? Nothing is published about what either half does at a higher dose. The membership is presumably fixed. The medication cost is unknown at any dose, so the question cannot be answered even in principle. 3. ## What the price includes No line here can be totaled. $99 is what the membership costs, not what treatment costs. MEDGm also states availability is subject to change on two lines. A figure that is explicitly one term of a sum is not a price, and it is not ranked here as one. 4. ## What it claims, and what it cites The lines reference approved products prescribed off-label rather than compounded preparations. Off-label prescribing is lawful and common. MEDGm states it directly, which is worth more than most disclosure on this subject. ## Where it holds up, and where it does not - Strength: The off-label position is stated outright - Strength: The pricing formula is printed, not implied - Strength: Coverage stated across 51 jurisdictions - Limitation: No medication cost appears anywhere - Limitation: No line can be totaled - Limitation: Availability is flagged as changeable - Limitation: Dose behavior is unknowable here ## What the evidence says about this kind of treatment The assessment above is about MEDGm. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who values a plain statement of the off-label position and will price the drug elsewhere. Wrong for A reader who needs to know what treatment costs before joining. ## The evidence behind what MEDGm prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How MEDGm compares | Seller | Who it suits | Go | | --- | --- | --- | | NextMeds | A reader who wants one charge covering medication and care, at a rate stated to hold from the first order. | | | Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | | | Alloy | A reader comparing three molecules at one seller, where the same fixed fee sits on top of each of them. | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [AlyveRx](https://thisglp.com/reviews/alyverx) [AM Rx](https://thisglp.com/reviews/amrx) [Amazon One Medical](https://thisglp.com/reviews/amazon-one-medical) [Amble](https://thisglp.com/reviews/amble) [Andrew Meds](https://thisglp.com/reviews/andrew-meds) [Apex MD](https://thisglp.com/reviews/apex-md) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What does $99 buy? The membership. MEDGm writes the formula as 'Membership + Cost' and does not publish the second term. Is the drug approved? MEDGm states Ozempic is FDA-approved for type 2 diabetes and prescribed off-label here for weight. That is a plainer statement than most sellers make. Can six months be estimated? No. Half the sum is missing at every dose, so no total is available at any commitment length. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).